Literature DB >> 10153432

Assessing the benefits of health care: how far should we go?

M Ryan1, P Shackley.   

Abstract

Mesh:

Year:  1995        PMID: 10153432      PMCID: PMC1055319          DOI: 10.1136/qshc.4.3.207

Source DB:  PubMed          Journal:  Qual Health Care        ISSN: 0963-8172


× No keyword cloud information.
  26 in total

1.  Assessing utilities by means of conjoint measurement: an application in medical decision analysis.

Authors:  A Maas; L Stalpers
Journal:  Med Decis Making       Date:  1992 Oct-Dec       Impact factor: 2.583

Review 2.  Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

Authors:  R J Labelle; J E Hurley
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

3.  Health related quality of life measurement--Euro style.

Authors:  R A Carr-Hill
Journal:  Health Policy       Date:  1992       Impact factor: 2.980

4.  Surveys of patients satisfaction: I--Important general considerations.

Authors:  R Fitzpatrick
Journal:  BMJ       Date:  1991-04-13

5.  An alternative to QALYs: the saved young life equivalent (SAVE)

Authors:  E Nord
Journal:  BMJ       Date:  1992-10-10

6.  Consumer satisfaction with breast screening: a pilot study.

Authors:  A Elkind; A Eardley
Journal:  J Public Health Med       Date:  1990-02

7.  Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

8.  Castigating QALYs.

Authors:  J Rawles
Journal:  J Med Ethics       Date:  1989-09       Impact factor: 2.903

9.  Ante-natal screening: what constitutes 'benefit'?

Authors:  G Mooney; M Lange
Journal:  Soc Sci Med       Date:  1993-10       Impact factor: 4.634

10.  Patient information-seeking behaviors when communicating with doctors.

Authors:  A E Beisecker; T D Beisecker
Journal:  Med Care       Date:  1990-01       Impact factor: 2.983

View more
  13 in total

Review 1.  Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Authors:  J Brown; M Sculpher
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 2.  Economic approaches to doctor/nurse skill mix: problems, pitfalls, and partial solutions.

Authors:  David Kernick; Anthony Scott
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

Review 3.  Economics notes: measuring outcomes in economic evaluations.

Authors:  D Torgerson; J Raftery
Journal:  BMJ       Date:  1999-05-22

Review 4.  Has health economics lost its way?

Authors:  D P Kernick
Journal:  BMJ       Date:  1998-07-18

5.  Economic evaluation in health: a thumb nail sketch.

Authors:  D P Kernick
Journal:  BMJ       Date:  1998-05-30

6.  An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments.

Authors:  Lidia Engel; Duncan Mortimer; Stirling Bryan; Scott A Lear; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

7.  Cancer patients' willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network.

Authors:  Nathalie Havet; Magali Morelle; Raphaël Remonnay; Marie-Odile Carrere
Journal:  Eur J Health Econ       Date:  2011-06-10

8.  Empirical Validity of a Generic, Preference-Based Capability Wellbeing Instrument (ICECAP-A) in the Context of Spinal Cord Injury.

Authors:  Cassandra Mah; Vanessa K Noonan; Stirling Bryan; David G T Whitehurst
Journal:  Patient       Date:  2021-03       Impact factor: 3.883

9.  QALYs and carers.

Authors:  Hareth Al-Janabi; Terry N Flynn; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

Review 10.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.